<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-KT9BRB56</identifier><date>2002</date><creator>Krajc, Mateja</creator><creator>Matos, Erika</creator><creator>Zakotnik, Branko</creator><relation>documents/doc/K/URN_NBN_SI_doc-KT9BRB56_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-KT9BRB56_001.txt</relation><format format_type="issue">1</format><format format_type="volume">6</format><format format_type="type">article</format><format format_type="extent">str. 35-37</format><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID">15029977</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-KT9BRB56</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Antagonists and inhibitors</subject><subject language_type_id="slv">Beljakovina-tirozinska kinaza</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="eng">Gastrointestinal neoplasms</subject><subject language_type_id="slv">Gastrointestinalne novotvorbe</subject><subject language_type_id="slv">gastrointestinalni sistem</subject><subject language_type_id="eng">Mesylates</subject><subject language_type_id="slv">Mezilati</subject><subject language_type_id="eng">Protein-tyrosine kinase</subject><subject language_type_id="slv">rak (medicina)</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Imatinib mesylat (inhibitor tirozin kinaze) za zdravljenje bolnikov z gastrointestinalnimi stromalnimi tumorji</title></Record>